Integrated microbiome and metabolome analysis reveals synergistic efficacy of basil polysaccharide and gefitinib in lung cancer through modulation of gut microbiota and fecal metabolites
Authors:
- Bing FengBFBing Feng
- Ying ZhuYZYing Zhu
- Zuqing SuZSZuqing Su
- Lipeng TangLTLipeng Tang
- 12 November 2024
- journal article
- research article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 281 (Pt 2) , 135992
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Lung cancer statistics, 2023Cancer, 2024
- Dietary medium-chain fatty acids and risk of incident colorectal cancer in a predominantly low-income population: a report from the Southern Community Cohort StudyThe American Journal of Clinical Nutrition, 2023
- Arginase: An emerging and promising therapeutic target for cancer treatmentBiomedicine & Pharmacotherapy, 2022
- Apigenin 7-O-glucoside promotes cell apoptosis through the PTEN/PI3K/AKT pathway and inhibits cell migration in cervical cancer HeLa cellsFood and Chemical Toxicology, 2020
- Basil polysaccharides: A review on extraction, bioactivities and pharmacological applicationsBioorganic & Medicinal Chemistry, 2020
- Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancerNMR in Biomedicine, 2019
- Parabacteroides distasonis Alleviates Obesity and Metabolic Dysfunctions via Production of Succinate and Secondary Bile AcidsCell Reports, 2019
- Basil polysaccharide attenuates hepatocellular carcinoma metastasis in rat by suppressing H3K9me2 histone methylation under hepatic artery ligation-induced hypoxiaInternational Journal of Biological Macromolecules, 2018
- Kynurenic acid inhibits colon cancer proliferation in vitro: effects on signaling pathwaysAmino Acids, 2014
- The major vault protein mediates resistance to epidermal growth factor receptor inhibition in human hepatoma cellsCancer Letters, 2012